BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Navarro-Romero A, Montpeyó M, Martinez-Vicente M. The Emerging Role of the Lysosome in Parkinson's Disease. Cells 2020;9:E2399. [PMID: 33147750 DOI: 10.3390/cells9112399] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Naren P, Cholkar A, Kamble S, Samim KS, Srivastava S, Madan J, Mehra N, Tiwari V, Singh SB, Khatri DK. Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay. JAD 2022. [DOI: 10.3233/jad-220682] [Reference Citation Analysis]
2 Yang Q, Li Y, Li B, Gong Y. A novel multi-class classification model for schizophrenia, bipolar disorder and healthy controls using comprehensive transcriptomic data. Comput Biol Med 2022;148:105956. [PMID: 35981456 DOI: 10.1016/j.compbiomed.2022.105956] [Reference Citation Analysis]
3 Raghunathan R, Turajane K, Wong LC. Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson’s Disease. IJMS 2022;23:9299. [DOI: 10.3390/ijms23169299] [Reference Citation Analysis]
4 Karayel O, Virreira Winter S, Padmanabhan S, Kuras YI, Vu DT, Tuncali I, Merchant K, Wills AM, Scherzer CR, Mann M. Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease. Cell Rep Med 2022;3:100661. [PMID: 35732154 DOI: 10.1016/j.xcrm.2022.100661] [Reference Citation Analysis]
5 Albanese F, Domenicale C, Volta M, Morari M. Modeling Parkinson's disease in LRRK2 mice: focus on synaptic dysfunction and the autophagy-lysosomal pathway. Biochem Soc Trans 2022;50:621-32. [PMID: 35225340 DOI: 10.1042/BST20211288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Potjewyd FM, Axtman AD. Exploration of Aberrant E3 Ligases Implicated in Alzheimer's Disease and Development of Chemical Tools to Modulate Their Function. Front Cell Neurosci 2021;15:768655. [PMID: 34867205 DOI: 10.3389/fncel.2021.768655] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Li LL, Lv WY, Wang Y, Li YF, Li CM, Huang CZ. DNA Logic Nanodevices for Real-Time Monitoring of ATP in Lysosomes. Anal Chem 2021;93:15331-9. [PMID: 34756034 DOI: 10.1021/acs.analchem.1c02829] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Wu HC, Chang KH, Chiang MC, Chen CM. Alterations of Plasma Galectin-3 and C3 Levels in Patients with Parkinson's Disease. Brain Sci 2021;11:1515. [PMID: 34827514 DOI: 10.3390/brainsci11111515] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Toro C, Zainab M, Tifft CJ. The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment. Neurosci Lett 2021;764:136195. [PMID: 34450229 DOI: 10.1016/j.neulet.2021.136195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Hu K, Gaire BP, Subedi L, Arya A, Teramoto H, Liu C, Hu B. Interruption of Endolysosomal Trafficking After Focal Brain Ischemia. Front Mol Neurosci 2021;14:719100. [PMID: 34650402 DOI: 10.3389/fnmol.2021.719100] [Reference Citation Analysis]
11 Signorelli P, Conte C, Albi E. The Multiple Roles of Sphingomyelin in Parkinson's Disease. Biomolecules 2021;11:1311. [PMID: 34572524 DOI: 10.3390/biom11091311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yuan D, Hu K, Loke CM, Teramoto H, Liu C, Hu B. Interruption of endolysosomal trafficking leads to stroke brain injury. Exp Neurol 2021;345:113827. [PMID: 34363809 DOI: 10.1016/j.expneurol.2021.113827] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Hur EM, Lee BD. LRRK2 at the Crossroad of Aging and Parkinson's Disease. Genes (Basel) 2021;12:505. [PMID: 33805527 DOI: 10.3390/genes12040505] [Cited by in F6Publishing: 2] [Reference Citation Analysis]